Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 10, No 4 (2018) Approaches to therapy for depressions in neurology: prospects for the use of agomelatine Abstract  similar documents
D. V. Romanov, B. A. Volel, D. S. Petelin
"... of patients with post-stroke depression, Parkinson’s disease, Alzheimer’s disease, Pick’s disease, Huntington’s ..."
 
Vol 11, No 1 (2019) Antidepressant therapy in patients with cardiovascular diseases Abstract  similar documents
V. E. Medvedev, E. A. Korovyakova, V. I. Frolova, E. V. Gushanskaya
"... the high efficiency and good tolerability of agomelatine, an antidepressant with an innovative mechanism ..."
 
Vol 11, No 2 (2019) Differentiated approach and indications for optimization of agomelatine therapy for endogenous depression Abstract  similar documents
L. I. Abramova, G. P. Panteleeva, I. Yu. Nikiforova, T. E. Novozhenova
"... Objective: to develop and justify differentiated indications for the use of agomelatine (valdoxan ..."
 
Vol 3, No 2 (2011) Role of melatonin in the treatment of depression Abstract  similar documents
Ol'ga Vladimirovna Kotova, Olga Vladimirovna Kotova
"... a wide range of drugs that are able to affect melatonin metabolism, amongst which there is agomelatine ..."
 
Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders Mental disorders in Huntington’s disease Abstract  similar documents
S. A. Klyushnikov, E. N. Yudina, S. N. Illarioshkin, I. A. Ivanova-Smolenskaya
"... нарушения при болезни Гентингтона Mental disorders in Huntington’s disease S.A. Klyushnikov, E.N. Yudina ..."
 
Vol 6, No 2 (2014) Predementia states and dementia in young people Abstract  similar documents
A.A. Smirnov, A.V. Gustov, S.V. Kopishinskaya, V.A. Antonova
"... in patients with neuroAIDS, Huntington’s disease, or multiple sclerosis. ..."
 
Vol 5, No 4 (2013) A case of Niemann – Pick disease type C Abstract  similar documents
Sergei Anatolyevich Klyushnikov, O R Smirnov, E Yu Zakharova
"... The paper describes a clinical case of a 27-year-old female patient with Niemann – Pick disease ..."
 
Vol 8, No 3 (2016) A clinical case of adult onset Niemann–Pick disease type C Abstract  similar documents
E. V. Saifullina, R. V. Magzhanov, A. K. Mardanova, T. Yu. Proshlyakova, E. Yu. Zakharova, S. A. Klyushnikov, S. N. Illarioshkin
"... The paper presents a brief review of an update of the etiology and pathogenesis of Niemann–Pick ..."
 
Vol 4, No 2 (2012) Sigma receptors: their role in the treatment of affective disorders  similar documents
V E Medvedev
 
Vol 4, No 3 (2012) Efficacy of valdoxan in the prevention and treatment of post-stroke depression Abstract  similar documents
Dina Rustemovna Khasanova, Yu V Zhitkova, A A Safiullina
"... The efficacy of valdoxan (agomelatine) used to prevent and treat post-stroke depression ..."
 
Vol 6, No 3 (2014) Current therapy for Parkinson's disease Abstract  similar documents
A. V. Obukhova
"... in the nigrostriatal system. Levodopa preparations and dopamine receptor agonists (DRAs) that are prescribed ..."
 
Vol 3, No 4 (2011) Parkinson's disease fatigability and its correction with the dopamine receptor agonist pramipexole Abstract  similar documents
Marina Romanovna Nodel
"... therapy with the dopamine receptor agonist pramipexole (Mirapex). Patients and methods ..."
 
Vol 4, No 2 (2012) Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease Abstract  similar documents
S N Illarioshkin
"... receptor agonists (DRA) remains the leading pharmacotherapeutic strategy for Parkinson’s disease (PD ..."
 
Vol 6, No 2S (2014): Special issue "Stroke" NMDA receptor antagonists in the treatment of patients with vascular cognitive imprairments Abstract  similar documents
I.S. Preobrazhenskaya
"... The paper discusses the possibilities of using the NMDA receptor antagonist memantine in patients ..."
 
Vol 2, No 3 (2010) Treatment of parkinson's disease ata young age Abstract  similar documents
Dmitry Valeryevich Artemyev
"... . Emphasis is laid on the key role of non-ergoline dopamine receptor agonists in the treatment of patients ..."
 
Vol 4, No 3 (2012) Clinical experience with requip modutab Abstract  similar documents
Denis Valeryevich Zakharov, V A Mikhailov
"... The efficacy of dopamine receptor agonists (DRAs) is determined by a number of advantages. DRAs ..."
 
Vol 4, No 1 (2012) Sustained-release pramipexole in the treatment of Parkinson’s disease Abstract  similar documents
Natalia Vladimirovna Fedorova
"... Dopamine (DA) receptor agonists ensure stimulation of DA receptors in the brain, by compensating ..."
 
Vol 10, No 2 (2018) Current management tactics for patients with dementia Abstract  similar documents
A. V. Medvedeva, O. V. Kosivtsova, K. A. Makhinov
"... inhibitors and N-methyl-D-aspartate (NMDA) glutamate receptor antagonists. Atypical neuroleptics are employed ..."
 
Vol 5, No 3 (2013) The efficacy of the dopamine agonist Rotigotine in the treatment of Parkinson's disease Abstract  similar documents
Marina Romanovna Nodel
"... Rotigotine is a new, non-ergot dopamine receptor agonist (DRA) formulated as a transdermal drug ..."
 
Vol 4, No 1 (2012) Association of the dopamine receptor (DRD4, DAT) gene polymorphisms with vital exhaustion in an open population among 25—64-year-old men (Novosibirsk): Epidemiological study according to the WHO MONICA-psychosocial program Abstract  similar documents
Valery Vasilyevich Gafarov, M I Voyevoda, E A Gromova, V N Maksimov, A V Gafarova, I V Gagulin, N S Yudin, T M Mishakova
"... of Medical Sciences (Novosibirsk). Results. The genotype containing allele 7 in the dopamine receptor subtype ..."
 
Vol 8, No 2 (2016) Alzheimer's disease under the mask of stroke Abstract  similar documents
A. A. Naumenko, N. V. Vakhnina
"... and vascular CIs are acetylcholinesterase inhibitors and N-methyl-D-aspartate receptor antagonists ..."
 
Vol 8, No 4 (2016) ALZHEIMER’S DISEASE: DIAGNOSIS AND TREATMENT Abstract  similar documents
A. A. Naumenko, D. O. Gromova, N. V. Trofimova, I. S. Preobrazhenskaya
"... ; basic symptomatic treatment; central acetylcholinesterase inhibitors; NMDA receptor blockers; akatinol ..."
 
Vol 10, No 4 (2018) Cognitive and motor training for patients with moderate cognitive impairment and mild dementia Abstract  similar documents
A. A. Naumenko, I. S. Preobrazhenskaya
 
Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders Cognitive and neuropsychiatric disorders in extrapyramidal diseases Abstract  similar documents
O. S. Levin, M. A. Anikin, E. E. Vasenina
"... of Parkinson’s disease or Huntington’s disease in persons who are predisposed to these diseases. Moreover ..."
 
Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания Non-drug therapies for cognitive impairment Abstract  similar documents
I. S. Preobrazhenskaya, D. Fantalis, S. A. Abdyshova, A. A. Kindarova
 
Vol 3, No 2 (2011) Use of cereton in neurological care Abstract  similar documents
Yuliya Aleksandrovna Starchina, Yulia Aleksandrovna Starchina
"... мелатонина). Имеется большой спектр препаратов, в том числе агомелатин и флувоксамин, способных влиять на ..."
 
Vol 9, No 2 (2017) Chemoreactomic analysis of thiamine disulfide, thiamine hydrochloride, and benfotiamine molecules Abstract  similar documents
O. A. Gromova, I. Yu. Torshin, L. V. Stakhovskaya, L. E. Fedotova
"... that thiamine disulfide can inhibit the molecular receptors involved in blood pressure regulation: adrenoceptors ..."
 
Vol 8, No 2 (2016) Therapy for depression in bipolar affective disorder Abstract  similar documents
N. A. Tyuvina, I. G. Korobkova
"... мелатонинергического АД агомелатина в отношении депрессивной симптоматики при БАР и прак- тическое отсутствие инверсии ..."
 
Vol 10, No 2 (2018) Molecular mechanisms of action of glucosamine sulfate in the treatment of degenerative-dystrophic diseases of the joints and spine: results of proteomic analysis Abstract  similar documents
O. A. Gromova, I. Yu. Torshin, A. M. Lila, A. N. Gromov
"... and discussion. GS interacts with the receptors CD44, TLR4, and ICAM1 on the surface of chondrocytes, inhibits ..."
 
Vol 5, No 1 (2013) Blood pressure lowering-based prevention and the POWER trial Abstract  similar documents
Vladimir Anatolyevich Parfenov, S V Verbitskaya
"... results of the POWER trial evaluating the safety and efficacy of eprosartan, an angiotensin receptor ..."
 
Vol 5, No 2S (2013): Special issue "Stroke" Management of patients with post-stroke dementia Abstract  similar documents
Svetlana Viktorovna Verbitskaya
"... the efficacy of central acetylcholinesterase inhibitors and the NMDA receptor antagonist akatinol memantine ..."
 
Vol 5, No 4 (2013) Dementia: epidemiology, clinical picture, diagnosis, approaches to therapy Abstract  similar documents
Irina Sergeyevna Preobrazhenskaya
"... to the pathogenetic therapy for dementia and the efficiency and safety of using NMDA receptor antagonists in patients ..."
 
Vol 4, No 1 (2012) Antyhypertensive therapy-based secondary prevention of ischemic stroke Abstract  similar documents
Vladimir Anatolyevich Parfenov, S V Verbitskaya, Yu A Starchina
"... ischemic attack. The possible neuroprotective effects of angiotensin II receptor blockers are discussed ..."
 
Vol 8, No 3 (2016) Systematic analysis of basic and clinical studies of etifoxine Abstract  similar documents
I. Yu. Torshin, O. A. Gromova, V. A. Semenov, T. R. Grishina
"... . The anxiolytic effect of etifoxine is due, firstly, to the modulation of GABA receptor activity and, secondly ..."
 
Vol 5, No 1 (2013) Depression therapy optimization at the present stage of development of psychopharmacology Abstract  similar documents
Dmitry Sergeyevich Danilov
"... . К ним относится мелатонинергический антидепрессант агомелатин, который не влияет на внеклеточный ..."
 
Vol 4, No 3 (2012) Cognitive impairments in young people with opioid addiction and their correction Abstract  similar documents
Maria Lazarevna Chukhlovina
"... медицинский университет» Россздрава Представлен анализ эффективности вальдоксана (агомелатин) в профилактике ..."
 
Vol 8, No 4 (2016) NEUROTROPHIC EFFECTS OF ETIFOXINE Abstract  similar documents
I. Yu. Torshin, O. A. Gromova, V. A. Semenov, O. A. Limanova, I. V. Gogoleva
"... ; these are to relieve allodynia related to 3α-steroids and GABA receptors and to effectively treat cerebral edema ..."
 
Vol 10, No 1 (2018) Cranial dystonia Abstract  similar documents
V. A. Tolmacheva
"... and from the receptors within it. Botulinum toxin preparations show the highest efficacy in treating ..."
 
Vol 8, No 3 (2016) Chemoreactome analysis of ethylmethylhydroxypyridine succinate Abstract  similar documents
O. A. Gromova, I. Yu. Torshin, L. E. Fedotova, A. N. Gromov
"... of acetylcholine and GABA receptors, as well as that of cannabinoid receptor type 2. The anti-inflammatory effect ..."
 
Vol 8, No 2 (2016) Effects of etifoxine: Chemoreactome simulation Abstract  similar documents
I. Yu. Torshin, O. A. Gromova, L. E. Fedotova, A. N. Gromov
"... neurotransmitter receptors; 2) anti-inflammatory activity; 3) the effect on hemodynamics and vascular walls; 4 ..."
 
Vol 10, No 1 (2018) Vascular myelopathy: causes and mechanisms, possibilities of diagnosis and treatment Abstract  similar documents
G. V. Ponomarev, A. A. Skoromets, V. S. Krasnov, O. V. Rodionova, D. D. Glistenkova, N. F. Porkhun, S. A. Dambinova
"... stages. The investigation and introduction of specific biochemical markers (glutamate receptors ..."
 
Vol 11, No 1 (2019) Molecular mechanisms of myoprotective action of chondroitin sulfate and glucosamine sulfate in sarcopenia Abstract  similar documents
O. A. Gromova, I. Yu. Torshin, A. M. Lila, N. A. Shostak, K. V. Rudakov
"... with CD44 receptor, the CS/GS molecules inactivate the proinflammatory factor NF-kB, the activity of which ..."
 
Vol 3, No 1 (2011) Heart rhythm variability analysis in patients with Levy body dementiaand in those with Parkinson's disease Abstract  similar documents
I G Tishkova, Irina Sergeevna Preobrazhenskaya, I G Tishkova, Irina Sergeyevna Preobrazhenskaya
"... probably caused by the hypersensitivity of denervated receptors to humoral factors. As the denervation ..."
 
Vol 10, No 1S (2018): СПЕЦВЫПУСК: ЭПИЛЕПСИЯ The role of neuroinflammation in the pathogenesis of epilepsy Abstract  similar documents
L. V. Lipatova, N. B. Serebryanaya, N. A. Sivakova
"... ), IL-1 receptor  antagonist (IL-1RA), soluble IL-2 receptor (sIL-2R), brain- derived neurotrophic ..."
 
Vol 10, No 2 (2018) Parkinson's disease and polymorphisms of the glutamatergic system genes GRIN2A, SLC1A2, and GRIK4 Abstract  similar documents
Yu. S. Mironova, I. A. Zhukova, N. G. Zhukova, S. A. Ivanova, V. M. Alifirova, A. S. Boiko, D. Z. Osmanova, O. P. Izhboldina, A. V. Latypova
"... ) receptor; SLC1A2 encoding the glial glutamate transporter; and GRIK4 encoding the ionotropic glutamate ..."
 
Vol 5, No 1 (2013) Dopamine dysregulation syndrome in Parkinson’s disease Abstract  similar documents
A V Nikitina, Natalia Vladimirovna Fedorova
"... or hypersexuality, the dose of dopaminergic receptor agonists was gradually reduced and subsequently discontinued. ..."
 
Vol 6, No 1S (2014): Special issue "Epilepsy" Genetics of Epilepsy: What for and How to Examine Children with Epilepsy E.D. Belousova Abstract  similar documents
E. D. Belousova
"... the alpha subunit of NMDA receptors was muted in 17.6% of children with this syndrome. The need ..."
 
Vol 7, No 1 (2015) Current therapy for chronic cerebrovascular attack Abstract  similar documents
A. A. Shmonin, V. S. Krasnov, I. A. Shmonina, E. V. Melnikova
"... , donepezil) and a reversible NMDA receptor blocker (memantine) are symptomatically used at a stage ..."
 
Vol 7, No 4 (2015) Possibilities of using naftidrofuryl in the therapy of cerebrovascular diseases: Literature review and the authors’ observations Abstract  similar documents
A. N. Belova, D. N. Shakurova, E. V. Gayazova
"... of a review of the Russian and foreign literature. Naftidrofuryl is a seroton 5-HT2 receptor antagonist ..."
 
Vol 9, No 1 (2017) The triple synergy of ethylmethylhydroxypyridine succinate, magnesium, and vitamin B6: Molecular mechanisms Abstract  similar documents
O. A. Gromova, A. G. Kalacheva, I. Yu. Torshin, T. R. Grishina, I. K. Tomilova
"... and neuromuscular transmission, to reduce anxiety, by activating acetylcholine, GABA, and dopamine receptors ..."
 
1 - 50 of 105 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)